
1,5-Diazabicyclo[4.3.0]non-5-ene | CAS:3001-72-7
1,5-Diazabicyclo[4.3.0]non-5-ene
- Name:1,5-Diazabicyclo[4.3.0]non-5-ene
- CAS:3001-72-7
- Synonyms:DBN
- Molecular Formula:C7H12N2
- Molecular Weight:124.18
- EINESC:221-087-3
Description
Properties
Water Solubility | soluble |
---|---|
Boiling point | 95-98 ºC (7.5 mmHg) |
Flash point | 94 ºC |
Density | 1.005 |
Refractive index | 1.519-1.521 |
Safety
Symbol(GHS) | C |
---|---|
Hazard Codes | R34 |
SDS/MSDS | S26;S36/37/39;S45 |
SDS
Source | SDS/MSDS Samples |
---|---|
Alfa-Aesar | View & Download |
Sigma-Aldrich | View & Download |
TCI | View & Download |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
A Comparison of the α2/3/5 Selective Positive Allosteric Modulators L-838,417 and TPA023 in Preclinical Models of Inflammatory and Neuropathic Pain.Sarah Nickolls et al.Advances in pharmacological sciences, 2011, 608912-608912 (2011-12-14)
Selective catalytic etherification of glycerol formal and solketal with dialkyl carbonates and K2CO3.Selva M, et al. Green Chemistry, 14(1), 188-200 (2012)
4-Substituted dioxolanes by chemoselective reactions on glycerol formal.Gras JL, et al. Tetrahedron Letters, 34(27), 4335-4336 (1993)
Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.Kazuo Hotta et al.Anticancer research, 35(9), 4681-4689 (2015-08-09)
Activation by thymidine kinase and potent antiherpetic activity of 2'-nor-2'-deoxyguanosine (2' NDG).Ashton WT, et al. Biochemical and Biophysical Research Communications, 108(4), 1716-1721 (1982)
A note on glycerol formal as a solvent in toxicity testing.Sanderson DM. The Journal of Pharmacy and Pharmacology, 11(1), 150-156 (1959)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!